Trial intelligence / Profile preview

Hexvix Flexible vs White Light Cystoscopy in Bladder Cancer

NCT01551407Phase 2Terminated

Sponsor
Photocure
Start
Dec 2011
Primary completion
Jun 2012
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of hexaminolevulinate in bladder cancer, sponsored by Photocure. Started Dec 2011; status: terminated.

02

Drugs

hexaminolevulinate
03

Conditions

bladder cancer

Beyond the preview

Go deeper on NCT01551407.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01551407.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call